The results showed that the levels of IL-1β, IL-6, TNF-α, and CRP mRNA in liver and aorta were significantly lower in the AAV-shRAGE group compared with the CML group (P < 0.05). This evidence concerns the gene CRP and chronic myelogenous leukemia, BCR-ABL1 positive.